Our analyses, focused specifically on JBCs, show a higher frequency of JBCs is CD21lo IgM+ memory B cells compared to non-JBCs from the same Jo-1 ARS patients. The gene discussed is CD40LG; the disease is Axenfeld-Rieger syndrome.